Andros Pharmaceuticals Co.,Ltd (TPEX:6917)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.25
-1.85 (-4.61%)
Apr 29, 2026, 1:53 PM CST
123.68%
Market Cap 1.74B
Revenue n/a
Net Income n/a
Shares Out 45.37M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 497,162
Average Volume 1,333,363
Open 39.85
Previous Close 40.10
Day's Range 37.85 - 39.85
52-Week Range 15.70 - 45.95
Beta -0.35
RSI 66.11
Earnings Date n/a

About TPEX:6917

Andros Pharmaceuticals Co.,Ltd, a biopharmaceutical company, engages in developing novel drug delivery platform technologies. The company develops APC101, a fast-drying, film-forming, and meter-dosed spray, which is in Phase IIa clinical trial to treat pain associated with post-herpetic neuralgia; APC201, a novel dosage form of topical anesthetic that is in Phase I/II clinical trial for treatment of Osteoarthritis; and siRNA, an anti-sense oligonucleotide and DNA candidate. Its preclinical phase products are APC310 and APC501 for anesthesia to ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6917
Full Company Profile

News

There is no news available yet.